本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Vir Biotechnology, Inc.

6.12
-0.1700-2.70%
盘后6.120.00000.00%17:48 EDT
成交量:87.66万
成交额:535.65万
市值:8.39亿
市盈率:-1.60
高:6.26
开:6.22
低:6.01
收:6.29
数据加载中...
2025/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/30

重要事件披露

Form 8-K - Current report
2025/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/01

重要事件披露

Form 8-K - Current report